Taro Pharmaceutical Industries (TARO) Nearly Doubles Q1 EPS to 1.06

Article Stock Quotes (1) Comments (0)

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) reported Q1 EPS of $1.06, versus $0.58 reported last year. Revenue for the quarter came in at $145.14 million, versus $107.73 million reported last year.

For earnings history and earnings-related data on Taro Pharmaceutical Industries Ltd. (TARO) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
• Natus Medical (BABY) Tops Q1 EPS by 4c; Nudges FY13 EPS Outlook Higher
• TiVo, Inc. (TIVO) Tops Q1 EPS by 6c; Issues Solid Q2 Rev Outlook

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?